ChinaNet Online Holdings Reports First Quarter 2020 Unaudited Financial Results
BEIJING, China, June 29, 2020 (GLOBE NEWSWIRE) — ChinaNet Online Holdings, Inc. (Nasdaq: CNET) (“ChinaNet” or the “Company”), an integrated […]
55 North Mining Inc. enters into a Binding Letter of Intent to Acquire the high grade Last Hope Gold Project in Manitoba Canada
TORONTO, June 29, 2020 (GLOBE NEWSWIRE) — 55 North Mining Inc. (“55 North” or the “Company”) announces that it has […]
Auxly Provides Update on Cultivation Strategy
TORONTO, June 29, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods […]
Acreage Holdings Closes Acquisition of Compassionate Care Foundation of New Jersey
NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage”) (CSE: ACRG.U) (OTC: ACRGF) (FSE: 0ZV) announced the […]
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020
CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]
XOMA Added to the Russell 2000® and Russell 3000® Indexes
EMERYVILLE, Calif., June 29, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) today announced the Company has been added to […]
Morphic Therapeutic Presents Positive Preclinical Data Supporting Development of MORF-057 in Inflammatory Bowel Disease at Digestive Disease Week 2020
Receptor occupancy, potency and selectivity data further build MORF-057 preclinical profile as an oral small molecule treatment candidate for IBDIND […]
Kiniksa Announces Positive Data from Phase 3 Trial of Rilonacept in Recurrent Pericarditis (RHAPSODY)
Primary and all major secondary efficacy endpoints were highly statistically significant Rilonacept treatment resulted in a 96% reduction in risk of […]
Resonant Inc. to Join Russell 2000® and 3000® Indexes
GOLETA, Calif., June 29, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]
TSX News -
Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia
Oral FLT3/BTK inhibitor CG-806 expands development beyond B-cell malignancies to the treatment of AMLPhase 1a/b study in B-cell malignancies continues […]
